The calls for a national track-and-trace system, which had died down when legislation was nixed last year, have been revived after more counterfeit cancer drugs have been discovered in the U.S. Story | Special Report
| Thursday, September 24th | 1pm ET / 10am PT | Sponsored by: M-Files
This webinar will discus how the emergence of the ability to share documents and data across thousands of miles instantly has pulled biopharma companies in two opposing directions. Companies want, even need, the interconnectivity that is facilitated by the Internet, but feel equally strongly about controlling who can view and interact with their data. Register today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!